Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis : a complex relationship with promising therapeutic opportunities
Copyright by Società Italiana di Nefrologia SIN, Rome, Italy..
In the last few years, the increasing awareness of the complex interaction between monoclonal component and renal damage has determined not only a new classification of the associated disorders, called Monoclonal Gammopathy of Renal Significance (MGRS), but has also contributed to emphasize the importance of an early diagnosis of the renal involvement, which is often hard to detect but can evolve towards terminal uraemia; it has also pointed at the need to treat these disorders with aggressive regimens, even if they are not strictly neoplastic. The case described here presented urinary abnormalities and renal failure secondary to a membranoproliferative glomerulonephritis (MPGN), with intensively positive immunofluorescence (IF) for monoclonal k light chain and C3, and in the absence of a neoplastic lympho-proliferative disorder documented on bone marrow biopsy. After the final diagnosis of MGRS, the patient was treated with several cycles of a therapy including dexamethasone, cyclophosphamide and bortezomib, showing a good functional and clinical response.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia - 36(2019), 4 vom: 24. Juli |
| Sprache: |
Italienisch |
|---|
| Beteiligte Personen: |
Manes, Massimo [VerfasserIn] |
|---|
| Anmerkungen: |
Date Completed 28.01.2020 Date Revised 28.01.2020 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM299848086 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM299848086 | ||
| 003 | DE-627 | ||
| 005 | 20231225101233.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||ita c | ||
| 028 | 5 | 2 | |a pubmed24n0999.xml |
| 035 | |a (DE-627)NLM299848086 | ||
| 035 | |a (NLM)31373468 | ||
| 035 | |a (PII)2019-vol4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Manes, Massimo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis |b a complex relationship with promising therapeutic opportunities |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.01.2020 | ||
| 500 | |a Date Revised 28.01.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright by Società Italiana di Nefrologia SIN, Rome, Italy. | ||
| 520 | |a In the last few years, the increasing awareness of the complex interaction between monoclonal component and renal damage has determined not only a new classification of the associated disorders, called Monoclonal Gammopathy of Renal Significance (MGRS), but has also contributed to emphasize the importance of an early diagnosis of the renal involvement, which is often hard to detect but can evolve towards terminal uraemia; it has also pointed at the need to treat these disorders with aggressive regimens, even if they are not strictly neoplastic. The case described here presented urinary abnormalities and renal failure secondary to a membranoproliferative glomerulonephritis (MPGN), with intensively positive immunofluorescence (IF) for monoclonal k light chain and C3, and in the absence of a neoplastic lympho-proliferative disorder documented on bone marrow biopsy. After the final diagnosis of MGRS, the patient was treated with several cycles of a therapy including dexamethasone, cyclophosphamide and bortezomib, showing a good functional and clinical response | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a kidney biopsy | |
| 650 | 4 | |a membranoproliferative glomerulonephritis | |
| 650 | 4 | |a monoclonal gammopathy of renal significance | |
| 650 | 7 | |a Glucocorticoids |2 NLM | |
| 650 | 7 | |a Immunoglobulin kappa-Chains |2 NLM | |
| 650 | 7 | |a Bortezomib |2 NLM | |
| 650 | 7 | |a 69G8BD63PP |2 NLM | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 650 | 7 | |a Complement C3c |2 NLM | |
| 650 | 7 | |a 80295-44-9 |2 NLM | |
| 650 | 7 | |a Cyclophosphamide |2 NLM | |
| 650 | 7 | |a 8N3DW7272P |2 NLM | |
| 700 | 1 | |a Radin, Elisabetta |e verfasserin |4 aut | |
| 700 | 1 | |a Pellu', Valentina |e verfasserin |4 aut | |
| 700 | 1 | |a Molino A, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Gabrielli, Danila |e verfasserin |4 aut | |
| 700 | 1 | |a Parodi, Emanuele |e verfasserin |4 aut | |
| 700 | 1 | |a Caputo, Donatella |e verfasserin |4 aut | |
| 700 | 1 | |a Paternoster, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Barreca, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Pagliaro, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Quattrocchio, Giacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Roccatello, Dario |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia |d 1997 |g 36(2019), 4 vom: 24. Juli |w (DE-627)NLM093699778 |x 1724-5990 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2019 |g number:4 |g day:24 |g month:07 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2019 |e 4 |b 24 |c 07 | ||